Robert Azelby

Robert Azelby

Fortune : 1 M $ au 30/09/2026

58 ans
Health Technology
Distribution Services
Consumer Services

Profil

Mr. Robert W.
Azelby
is a Chairman at Tango Therapeutics, Inc., an Independent Director at Cardinal Health, Inc. and an Independent Non-Executive Director at ADC Therapeutics SA. He is on the Board of Directors at Cardinal Health, Inc., Autolus Therapeutics Plc and ADC Therapeutics SA. Mr. Azelby was previously employed as an Independent Director by Terns Pharmaceuticals, Inc., a Chief Executive Officer by Masimo Corp., an Independent Director by Chinook Therapeutics, Inc., a President, Chief Executive Officer & Director by Eliem Therapeutics, Inc., an Independent Director by Clovis Oncology, Inc., a President, Chief Executive Officer & Director by Alder Biopharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Juno Therapeutics, Inc., a Vice President & General Manager-Oncology by Amgen, Inc., and a VP-Commercial Effectiveness Unit & General Manager by Amgen Europe BV.
He also served on the board at Immunomedics, Inc., CASCADIAN THERAPEUTICS INC and Alliance for Regenerative Medicine.
He received his undergraduate degree from the University of Virginia and an MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/09/2026 4 085 ( 0 % ) 908 913 $ 30/09/2026
19/06/2026 5 740 ( 0,01 % ) 143 213 $ 30/09/2026
03/06/2026 112 805 ( 0,09 % ) 137 622 $ 30/09/2026
29/06/2026 0 ( -.--% ) - $ 30/09/2026

Postes actifs de Robert Azelby

SociétésPosteDébut
ADC THERAPEUTICS SA Directeur/Membre du Conseil 14/06/2023
AUTOLUS THERAPEUTICS PLC Directeur/Membre du Conseil 09/01/2024
CARDINAL HEALTH, INC. Directeur/Membre du Conseil 01/03/2024
TANGO THERAPEUTICS, INC. Président 06/08/2026

Anciens postes connus de Robert Azelby

SociétésPosteFin
TERNS PHARMACEUTICALS, INC. Directeur/Membre du Conseil 05/05/2026
MASIMO CORPORATION Directeur Général 01/02/2025
CHINOOK THERAPEUTICS, INC. Directeur/Membre du Conseil 11/08/2023
CLOVIS ONCOLOGY, INC. Directeur/Membre du Conseil 10/07/2023
CLIMB BIO, INC. Directeur Général 13/02/2023
Voir l'expérience en détail de Robert Azelby

Formation de Robert Azelby

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

94

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Distribution Services

Health Technology

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Robert Azelby
🔇